Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
machine learning
MedTech
Thermo Fisher launches biopsy test to assess lung rejection risk
With Thermo Fisher’s new test, physicians can estimate the likelihood of rejection using molecular scores tied to injury and graft dysfunction.
Joseph Keenan
Oct 9, 2025 10:50am
Singapore drug discovery platform heads to Nasdaq via SPAC deal
Oct 2, 2025 9:50am
PhaseV launches trial optimization software into CRO's services
Sep 10, 2025 12:54pm
GI-focused CRO boosts trial tech with adaptive software
Feb 3, 2025 11:40am
Novo inks $50M metabolic disease pact with genomics biotech
Jan 7, 2025 10:35am
BigHat, Synaffix collab outfits AI science with ADC tech
Nov 4, 2024 11:07am
